Aliya Yakubova

Dr. Aliya Yakubova

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2020 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
AYAliya Yakubova
Aliya Yakubova
YDYuriy Davidyuk
Yuriy Davidyuk
Jussi TohkaJussi Tohka
Jussi Tohka
OKOlga Khayrutdinova
Olga Khayrutdinova
Igor KudryavtsevIgor Kudryavtsev
Igor Kudryavtsev
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov

1 January 2025 in Cephalalgia Reports
Verified
Journal Article
Open access
Dima Leila ChaarDima Leila Chaar
Dima Leila Chaar
AYAliya Yakubova
Aliya Yakubova
CJChen Jiang
Chen Jiang
THThomas J Hoffmann
Thomas J Hoffmann
APAlice Pressman
Alice Pressman
HCHélène Choquet
Hélène Choquet
Introduction: To investigate the association of genetically predicted migraine with the risk of primary open-angle glaucoma (POAG). Methods: To estimate the shared genetic basis of migraine and POAG, we conducted genome-wide genetic correlation analyses using cross-trait linkage disequilibrium score regression. To assess potential causal effects of migraine on POAG risk, we conducted two-sample Mendelian randomization (MR) analyses using data from European ancestry individuals. Genetic instruments (N = 54 genetic variants with minor allele frequency (MAF) ≥ 0.01) were derived from our previous genome-wide association study (GWAS) of migraine conducted in the UK Biobank (16,709 migraine cases and 438,178 controls). For POAG, we used GWAS summary statistics from our previous GWAS conducted in the GERA cohort (3836 POAG cases and 48,065 controls) or using data from the International Glaucoma Genetics Consortium (15,229 POAG cases and 177,473 controls). The inverse-variance weighted (IVW) method was our primary source of MR estimates and common sensitivity analyses were conducted. Results: We found that migraine was not genetically associated with POAG ( r g  = 0.05; SE = 0.11; P  = 0.69). Further, we did not detect any evidence of association between genetically predicted migraine with POAG. Conclusion: Our results provide evidence that genetic risk for migraine may not be a strong causal risk factor for POAG.

Verified
Journal Article
Open access
PDF file
SSSvetlana Olegovna Svitko
Svetlana Olegovna Svitko
EEElizaveta Ermakova
Elizaveta Ermakova
KLKarina libera350@gmail.com
Karina libera350@gmail.com
KBKsenia Bogatova
Ksenia Bogatova
NGNazgul Gaifutdinova
Nazgul Gaifutdinova
Guzel SitdikovaGuzel Sitdikova
Guzel Sitdikova
Migraine is characterized by severe pain and somatic symptoms like allodynia and photophobia, driven by neuroinflammation that sensitizes the trigeminal vascular system (TVS). This study investigated how neuroinflammation induced by systemic lipopolysaccharide (LPS) affects migraine-related nociceptive signaling. Using a chronic migraine model in rats with nitroglycerin (NTG), we compared prenatal and acute postnatal LPS administration. Rats with prenatal LPS exhibited lower mechanical thresholds and enhanced allodynia and photophobia after NTG. Acute LPS also increased allodynia, but not photophobia. Both LPS groups showed increased mast cell degranulation in the dura mater. Plasma CGRP after NTG administration was elevated in the acute LPS group. Electrophysiology revealed enhanced trigeminal afferent responses to serotonin in both acutely and prenatally LPS-treated rats. Calcium imaging demonstrated increased neuronal responses to serotonin and capsaicin, suggesting an upregulation of serotonin and TRPV1 receptors. Our findings show that LPS-induced neuroinflammation, whether prenatal or acute, promotes sensitization of peripheral and central nociceptive pathways, involving serotoninergic mechanisms.

15 January 2022 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
AYAliya Yakubova
Aliya Yakubova
ESElena Shagimardanova
Elena Shagimardanova
TGTatiana V. Grigoryeva
Tatiana V. Grigoryeva
BEBoulygina A. Eugenia
Boulygina A. Eugenia
LSLeyla Shigapova
Leyla Shigapova
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov


1 December 2023 in Current Pharmacogenomics and Personalized Medicine
Verified
Journal Article
Closed access
PDF file
AYAliya Yakubova
Aliya Yakubova
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
Background: Migraine is one of the most common diseases that significantly impairs the quality of life. This condition has a pronounced genetic component. Genes responsible for the development of monogenic forms of hemiplegic migraine have already been identified, and the search for genetic associations with common migraine and its subtypes continues. Objective: The aim of this study was to search for new potential genetic markers of migraine by analyzing available open genetic databases. Methods: The analysis included databases such as ClinVar, GWAS Catalog, UK Biobank and FinnGen. In all databases, the keyword "migraine" was used to search for migraineassociated variants. Genetic variants with clinical annotations "pathogenic" and "likely pathogenic" were selected from the variants in the ClinVar database. From other databases, variants with an association significance level of p ≤ 5×10-8 were chosen. Results: A total of 112 genetic variants associated with migraine were identified. After excluding polymorphisms known from previous migraine studies, it was found that 45 genetic variants were identified for the first time. Conclusion: These variants belong to various functional groups, including ion channels, enzymes, receptors, and regulatory proteins, confirming the current understanding of the polygenic nature of migraine. Identifying new genetic associations with migraine can contribute to a better understanding of its pathogenesis and open new possibilities for diagnosis and the development of more effective treatment strategies for this condition.